Top of page Skip navigation

Programme


12 July 
ON Helix Welcome Reception and BioNewsRound Award | EMBL-EBI

Time: 15.30-19.30 
Click here to register
 

12 July | Investor Dinner | Jointly Hosted with Cambridge Enterprise

Time: 19.30 - 21.30
Please email nadia@onenucleus.com if you would like to attend. 

______________________________________________________________
 

13 July | ON Helix 

Location: Wellcome Genome Campus Conference Centre, Hinxton
Time: 08.00-18.30
 

08.00 - Registration

08.50 - Welcome from One Nucleus
Harriet Fear, CEO, One Nucleus

Keynote Addresses

09.20 - Putting the C in Science: Commercialisation, Community and Capital
Sharon Vosmek, Astia

09.50 - Time for a Change...
David Pardoe, LifeArc

10.20 - Accelerating the Antibiotics Pipeline: AMR Centre and CARB-X
Pete Jackson, The AMR Centre

10.50 - Coffee Break

11.20 - Session 1: Choosing the Right Business Model

Chair:
Harren Jhoti, Astex Pharmaceuticals 

Panel:
Jane Dancer, F-star
Rene van der Merwe, MedImmune
Tony Kouzarides, The Milner Institute
Trevor Baglin, Medicxi

12.20 - Lunch, Exhibition and Ice Cream Van

13.00 - Workshop by UCL Translational Office

14.00 - From Understanding Biological Computation to Programming Cells
Sara-Jane Dunn, Microsoft

14.30 - Session 2: New Technologies in Translational Medicine

Chair:
Claire Thompson, Agility Health Tech

Panel:
Jackie Hunter, BenevolentAI
Eric Mayes
, Endomag
Billy Boyle, Owlstone Medical
Sam Whitehouse, QuantuMDx


15.30 - Coffee Break


16.15 - Session 3: Do Charities Make the Best Investors?

Chair:
Magda Papadaki, ABPI

Panel:
Nicolas SireauFindacure
Allan Marchington, Apposite Capital and Touchstone Innovations 
Hakan Goker, Merck Ventures
Lars Gredsted, Wellcome Trust

17.00 - Q & A with Keynote Speakers

Chair: 
Sir Mike Rawlins, MHRA

Keynote Speakers:
Sharon Vosmek, Astia
David Pardoe, LifeArc
Sara-Jane Dunn, Microsoft
Pete Jackson, The AMR Centre


17.30 - Closing Remarks and Drinks Reception
Harriet Fear, CEO, One Nucleus


18.30 - Close

 

Please note the programme is subject to change.


Media Partner


 

Partnering powered by